Leerink Revelation Partners and Industry Ventures-led investors acquires Three Arch's shares in AcelRx

Investors led by Leerink Revelation Partners and Industry Ventures have acquired all of the shares that were held by Three Arch in AcelRx Pharmaceuticals Inc, a specialty pharmaceutical company. No financial terms were disclosed for this secondary deal.

23 May 2018•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail